Organon & Co | OGN - Market Capitalization


Organon & Co reported $1.63B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Cspc Pharmaceutical CNY 87.29B 19.74B Dec/2025
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Divis Laboratories Ltd INR 1.7T 186.62B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
Glaxosmithkline GBP 99.93B 13.05B Dec/2025
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Knight Therapeutics CAD 600.53M 14.56M Dec/2025
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 142.92M 19.65M Feb/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Novartis USD 263.08B 17.01B Dec/2025
Organigram Holdings CAD 312.16M 66.64M Dec/2025
Organon & Co USD 1.86B 916.43M Dec/2025
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Pharma Mar EUR 1.35B 283.5M Dec/2025
Qiagen NV USD 9.9B 207.4M Dec/2025
Sartorius EUR 16.41B 2.95B Dec/2025
Zealand Pharma A/S 33.35B 0 Apr/2026